<!DOCTYPE html>
<html lang='en'>
  <head>
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-PK63DK');</script>
    <meta content='text/html; charset=UTF-8' http-equiv='Content-Type'>
    <meta charset='utf-8'>
    <meta content='width=device-width, initial-scale=1, shrink-to-fit=no' name='viewport'>
    <link crossorigin='anonymous' href='https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/css/bootstrap.min.css' integrity='sha384-WskhaSGFgHYWDcbwN70/dfYBj47jz9qbsMId/iRN3ewGhXQFZCSftd1LZCfmhktB' rel='stylesheet'>
    <link href='/styles.css' rel='stylesheet'>
    <title>Type 2 Diabetes: Patients Reporting Better Quality of...</title>
    <script async='async' src='https://www.googletagservices.com/tag/js/gpt.js'></script><script>var googletag=googletag ||{}; googletag.cmd=googletag.cmd || [];</script><script>googletag.cmd.push(function(){googletag.defineSlot('\/1010898\/sgforums_interstitial', [ 1.0 , 1.0], 'div-gpt-ad-1528181032761-0').setTargeting('forum', ['3513']).setTargeting('topic', ['488711']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_leaderboard', [[ 728.0 , 90.0], [ 970.0 , 250.0]], 'div-gpt-ad-1528181032761-1').setTargeting('forum', ['3513']).setTargeting('topic', ['488711']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_mpu', [ 300.0 , 250.0], 'div-gpt-ad-1528181032761-2').setTargeting('forum', ['3513']).setTargeting('topic', ['488711']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_supersky', [ 160.0 , 600.0], 'div-gpt-ad-1528181032761-3').setTargeting('forum', ['3513']).setTargeting('topic', ['488711']).addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices();});</script>
  </head>
  <body>
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PK63DK"height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <div class='container'>
      <a href='/'>Home</a>
      >
      <a href='/forums/3513/'>PR Newswire Asia</a>
      <h1>Type 2 Diabetes: Patients Reporting Better Quality of...</h1>
      <nav class='pagination'>
      </nav>
      <ul class='list-group posts'>
        <li class='list-group-item post'>
          <div class='row'>
            <div class='col-md-2 meta'>
              <div class='author'>Helen.zhang</div>
              <time class='date' datetime='2015-06-10T17:57:12+00:00'>10 Jun 15, 17:57</time>
            </div>
            <div class='col-md body'>
              <div id="dvContent" style="font-size: 12px; line-height: 1.6em; color: #464646; word-wrap: break-word; font-family: Arial, Helvetica, sans-serif;">
              <div id="subheadlines" style="font-size: 15px; font-weight: bold; line-height: 1.6em; font-style: italic;">-- 'Encouraging' and 'collaborative' physician communication is linked to better patient outcomes</div>
              <div id="subheadlines" style="font-size: 15px; font-weight: bold; line-height: 1.6em; font-style: italic;">-- New IntroDia™ Survey patient data are presented at American Diabetes Association's® (ADA) 75th Scientific Sessions</div>
              <div id="subheadlines" style="font-size: 15px; font-weight: bold; line-height: 1.6em; font-style: italic;">-- IntroDia™ is an initiative of Boehringer Ingelheim and Lilly in partnership with the International Diabetes Federation</div>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">INGELHEIM, <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">Germany</span> and <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">INDIANAPOLIS, Ind.</span>, /PRNewswire/ -- New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed ('add-on'), is linked to future patient self-care and well-being.<sup>1</sup> Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.*<sup>1</sup></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">The perceived quality of the 'add-on' conversation by patients was linked to all self-management outcomes surveyed.<sup>1 </sup>Patients who recalled better quality of communication when interacting with their physicians reported improved self-care and emotional well-being, including improved diabetes-related emotional distress, frequency of exercise and diet, as well as better medication adherence.<sup>1</sup></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Dr <span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">Matthew Capehorn</span>, UK, GP and member of the IntroDia™ Advisory Panel commented, "If not framed properly, the introduction of additional oral medication for type 2 diabetes management can be a challenging moment for patients. An encouraging conversation with a physician can make a real difference to subsequent self-management. We now have data that confirm how important the quality of communication is during this 'add-on' conversation."</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Analysis of the conversations indicated patients distinguish three types of physician statements that contribute to communication quality: 'encouraging', 'collaborative' and 'discouraging'.<sup>1</sup> When physicians used 'encouraging' and 'collaborative' statements, patients' perception of the communication quality significantly improved.<sup>1</sup> Using 'discouraging' statements had the opposite effect.<sup>1</sup></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">'Encouraging' communication included statements such as:</p>
              <ul style="margin: 5px 0px; list-style: none; padding-bottom: 10px; padding-left: 2em;" type="disc">
              <li style="list-style-image: none;">"My doctor explained that the new medication would help to control my diabetes." </li>
              <li style="list-style-image: none;">"My doctor told me that the new medication would improve my quality of life."</li>
              </ul>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">'Collaborative' communication examples were:</p>
              <ul style="margin: 5px 0px; list-style: none; padding-bottom: 10px; padding-left: 2em;" type="disc">
              <li style="list-style-image: none;">"My doctor invited me to ask questions about my new medication."</li>
              <li style="list-style-image: none;">"My doctor helped to adjust my treatment plan so I could do it in my daily life."</li>
              </ul>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">'Discouraging' communication included statements like:</p>
              <ul style="margin: 5px 0px; list-style: none; padding-bottom: 10px; padding-left: 2em;" type="disc">
              <li style="list-style-image: none;">"My doctor told me that my diabetes is out of control."</li>
              <li style="list-style-image: none;">"My doctor told me that I needed more medication because I had failed to take good enough care of myself."</li>
              </ul>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">The analysis also looked into which statements were most frequently recalled by patients from their 'add-on' conversations. 'Encouraging' statements were recalled by up to 85 percent of patients. 'Discouraging' statements were recalled by up to 53 percent of patients.<sup>1</sup></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">"The patient data demonstrate that physicians are already doing a good job, by most often using 'encouraging' and 'collaborative' statements and using 'discouraging' statements less frequently. However, 'add-on' conversations can still be further improved to help patients make the positive behavioural changes required to manage type 2 diabetes," concluded Dr Capehorn.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><span class="prnews_span" style="font-family: Arial; font-size: 8pt; color: black;">*4,235 people with T2D, out of the total 10,319 included in the IntroDia™ Survey, met the necessary criteria to be asked about 'add-on' moment conversations. All 10,319 survey participants were asked about their early 'diagnosis' conversations.</span></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong>CONTACT<br></strong><span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">Sungjin Kim</span><br>Head of Communications<br>Regional Operating Unit South East Asia and <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">South Korea</span><br>Boehringer Ingelheim Singapore Pte.Ltd. <br>Office: +65<span id="spanHghlt2ba9" style="font-family: Arial, 'Times New Roman', Times, serif;">-</span>6419<span id="spanHghlt2ba9" style="font-family: Arial, 'Times New Roman', Times, serif;">-</span>7625<br>Email: <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="mailto:Sungjin.kim@boehringer-ingelheim.com">Sungjin.kim@boehringer-ingelheim.com</a></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong>Reference</strong></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">1. Capehorn M, <em>et al. </em>Physician-patient Communication at Prescription of an Additional Oral Agent for Type 2 Diabetes (T2D): Link Between Key Conversation Elements, Physician Empathy and Patient Outcomes -- Insights From the Global IntroDia™ Study. Poster 63-LB at the 75th Scientific Sessions of the American Diabetes Association<sup>®</sup> (ADA) 2015, <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">Boston</span>, <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">USA</span>.</p>
              </div>
              <div id="dvSource" style="font-size: 12px; margin-top: 25px; margin-bottom: 5px; color: #666666; font-family: Arial, Simsun, Helvetica, sans-serif; line-height: 12px;">Source: Boehringer Ingelheim</div>
            </div>
          </div>
        </li>
        <li class='list-group-item'>
          <div id='div-gpt-ad-1528181032761-2' style='height:250px; width:300px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-2');});</script></div>
        </li>
      </ul>
      <nav class='pagination'>
      </nav>
      <footer>
        <nav class='nav'>
          <a class='nav-link' href='/'>Home</a>
          <a class='nav-link' href='/privacy/'>Privacy</a>
          <a class='nav-link' href='/terms/'>Terms</a>
        </nav>
      </footer>
    </div>
    <div id='div-gpt-ad-1528181032761-0' style='height:1px; width:1px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-0');});</script></div>
  </body>
</html>
